Michael S. Cuffe - Feb 13, 2025 Form 4 Insider Report for HCA Healthcare, Inc. (HCA)

Role: EVP and Chief Clinical Officer
Signature: /s/ Kevin A. Ball, Attorney-in-Fact
Stock symbol: HCA
Transactions as of: Feb 13, 2025
Transactions value $: -$187,679
Form type: 4
Date filed: 2/18/2025, 07:30 PM
Previous filing: Jan 30, 2025
SEC: View on sec.gov

Transactions Table

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Ownership	Footnotes
transaction	HCA	Common Stock	Award	$0	+2.33K	+7.85%	$0.00	32K	Feb 13, 2025	Direct	F1
transaction	HCA	Common Stock	Tax liability	-$188K	-583	-1.82%	$321.92	31.4K	Feb 13, 2025	Direct

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id	Content
F1	On January 28, 2022, the reporting person was granted 4,490 performance share units. The performance share units were eligible to vest based on achievement of a cumulative earnings per share goal for fiscal years 2022-2024. The number of performance share units that were eligible to vest varied from zero (for actual performance less than 90% of target) to two times the units granted (for actual performance of 110% or more of target). Based upon the Company's achievement with respect to cumulative 2022-2024 earnings per share, the number of performance share units that vested equaled 51.9% of the units granted.

Content

On January 28, 2022, the reporting person was granted 4,490 performance share units. The performance share units were eligible to vest based on achievement of a cumulative earnings per share goal for fiscal years 2022-2024. The number of performance share units that were eligible to vest varied from zero (for actual performance less than 90% of target) to two times the units granted (for actual performance of 110% or more of target). Based upon the Company's achievement with respect to cumulative 2022-2024 earnings per share, the number of performance share units that vested equaled 51.9% of the units granted.